We are live on ! Find out more
NGVT icon

Ingevity

265 hedge funds and large institutions have $2.19B invested in Ingevity in 2022 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 89 increasing their positions, 91 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

165% more call options, than puts

Call options by funds: $2.9M | Put options by funds: $1.09M

25% more funds holding in top 10

Funds holding in top 10: 45 (+1)

2% less repeat investments, than reductions

Existing positions increased: 89 | Existing positions reduced: 91

4% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 28

4% less capital invested

Capital invested by funds: $2.29B → $2.19B (-$99.7M)

2.27% less ownership

Funds ownership: 91.77%89.49% (-2.3%)

3% less funds holding

Funds holding: 274265 (-9)

Holders
265
Holders Change
-9
Holders Change %
-3.28%
% of All Funds
4.46%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.08%
New
27
Increased
89
Reduced
91
Closed
28
Calls
$2.9M
Puts
$1.09M
Net Calls
+$1.81M
Net Calls Change
+$1.14M

NGVT Hedge Fund Activity: Q2 2022 in Review

265 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Ingevity (NGVT) for Q2 2022, worth a combined $2.19B — down 4.3% from $2.29B a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of NGVT and 27 opened new positions — a net loss of 1 holder — while 91 trimmed existing stakes and 89 added.

The largest buyer was Morgan Stanley, adding an estimated $13.3M. The largest seller was Ardevora Asset Management, exiting entirely with an estimated $51.1M sold.

  • 265 institutional investors held Ingevity (NGVT) as of Q2 2022, down from 274 in Q1 2022.
  • Funds reported $2.19B of Ingevity stock for Q2 2022, down 4.3% quarter-over-quarter.
  • 27 funds opened new Ingevity positions in Q2 2022 and 28 closed out, a net change of -1 holder.
  • The largest Ingevity buyer in Q2 2022 was Morgan Stanley, an estimated $13.3M added.
  • The largest Ingevity seller in Q2 2022 was Ardevora Asset Management, an estimated $51.1M sold.

Based on aggregated 13F filings for Q2 2022.